Literature DB >> 28106614

Study of Intrapatient Variability and Reproducibility of Quantitative Tumor Perfusion Parameters Evaluated With Dynamic Contrast-Enhanced Ultrasonography.

Nathalie Lassau1, Bénédicte Coiffier, Laura Faivre, Baya Benatsou, Sophie Bidault, Elizabeth Girard, Bernard Asselain, Stéphanie Pitre-Champagnat, Serge Koscielny.   

Abstract

OBJECTIVES: Dynamic contrast-enhanced (DCE) ultrasonography (US) is a functional imaging technique enabling quantitative assessment of solid tumor perfusion in metastatic patients treated with antiangiogenic therapies.The objective of this prospective single-center study was to evaluate in real-life conditions (in routine clinical practice) the intrapatient variability and reproducibility of DCE-US parameters.
MATERIALS AND METHODS: Each patient provided written informed consent and had 2 DCE-US examinations (preprandial and postprandial) at baseline, day 15, and 1 month after treatment initiation. Perfusion curves were recorded after Sonovue injections to determine 7 perfusion parameters. Dynamic contrast-enhanced US examinations were analyzed in pairs: preprandial and postprandial. Log transformed values were used to determine the variability of the pairs (within-subject coefficient of variation) and their reproducibility (Spearman correlation coefficient).
RESULTS: We included 60 patients (23 colon cancers, 36 kidney cancers, and 1 breast cancer) treated with axitinib (26 patients), sunitinib (27 patients), and other antiangiogenic treatments (7 patients). The 60 patients included 38 men (63%) and 22 women (37%) with a median age of 62 (range, 25-82 years). Thirty patients had hepatic and 30 had extrahepatic target lesions. Data were analyzed for 128 pairs of DCE-US: 45 (baseline), 45 (day 15), and 38 (1 month). Preprandial and postprandial values were not significantly different. For area under the curve and area under the washout, the correlation coefficient between preprandial and postprandial values was 0.89; the associated within-subject coefficients of variation were 61% and 64%, respectively. However, the range of individual variations (postprandial value/preprandial value) was less than 2 logs for a range of parameter values of about 4 logs. Variability was independent of the metastatic site.
CONCLUSIONS: This study showed that area under the curve and area under the washout are the 2 most reproducible DCE-US parameters.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28106614     DOI: 10.1097/RLI.0000000000000324

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  6 in total

1.  Repeatability of the "flash-replenishment" method in contrast-enhanced ultrasound for the quantitative assessment of hepatic microvascular perfusion.

Authors:  Fang Xie; Wen-Bo Wan; Xiang Fei; Ming-Bo Zhang; Yan Zhang; Hong-Wei Wang; Jie Tang; Wen-Bo Tang; Yu-Kun Luo
Journal:  Braz J Med Biol Res       Date:  2018-02-26       Impact factor: 2.590

Review 2.  Monitoring of tumor vascular normalization: the key points from basic research to clinical application.

Authors:  Wei Li; Ying-Yao Quan; Yong Li; Ligong Lu; Min Cui
Journal:  Cancer Manag Res       Date:  2018-10-03       Impact factor: 3.989

Review 3.  Application of Multiparametric Intraoperative Ultrasound in Glioma Surgery.

Authors:  Ji Shi; Ye Zhang; Bing Yao; Peixin Sun; Yuanyuan Hao; Haozhe Piao; Xi Zhao
Journal:  Biomed Res Int       Date:  2021-04-16       Impact factor: 3.411

4.  Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker.

Authors:  Raphael Naccache; Younes Belkouchi; Littisha Lawrance; Baya Benatsou; Joya Hadchiti; Paul-Henry Cournede; Samy Ammari; Hugues Talbot; Nathalie Lassau
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

5.  Super-Resolution Contrast-Enhanced Ultrasound Methodology for the Identification of In Vivo Vascular Dynamics in 2D.

Authors:  Evangelos Kanoulas; Mairead Butler; Caitlin Rowley; Vasiliki Voulgaridou; Konstantinos Diamantis; William Colin Duncan; Alan McNeilly; Michalakis Averkiou; Hessel Wijkstra; Massimo Mischi; Rhodri Simon Wilson; Weiping Lu; Vassilis Sboros
Journal:  Invest Radiol       Date:  2019-08       Impact factor: 6.016

6.  Early response evaluation of doxorubicin-nanoparticle-microbubble therapy in orthotopic hepatocellular carcinoma rat model using contrast-enhanced ultrasound and intravoxel incoherent motion-diffusion MRI.

Authors:  Hyun Kyung Yang; Jung Hoon Kim; Hak Jong Lee; Hyungwon Moon; Hwaseong Ryu; Joon Koo Han
Journal:  Ultrasonography       Date:  2021-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.